190705_Biontech_Logo_RGB_Dark Green (Preferred)_0.png
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron
June 25, 2022 10:02 ET | BioNTech SE
Omicron-adapted monovalent candidate given as a fourth booster dose elicited a 13.5 and 19.6-fold increase in neutralizing geometric titers against Omicron BA.1 at 30 µg and 60 µg dose levels;...
Madrigal logo.jpg
Madrigal Pharmaceuticals Presents Late-Breaking Phase 3 NASH Data and Multiple Oral Abstracts at EASL’s International Liver Congress™
June 25, 2022 09:00 ET | Madrigal Pharmaceuticals, Inc.
Late-breaking data from the double-blind portion of the noninvasive Phase 3 MAESTRO NAFLD-1 study show resmetirom to be safe and well-tolerated and to reduce liver fat, fibrosis measures on FibroScan...
VIR_logo_large.jpg
Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program
June 25, 2022 07:00 ET | Vir Biotechnology, Inc.
– Results from ongoing trials of VIR-2218 and VIR-3434 presented at the International Liver Congress™ (ILC) 2022 demonstrate durable reductions in hepatitis B surface antigen with no safety signals – ...
Arbutus Biopharma Logo
Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update
June 25, 2022 04:05 ET | Arbutus Biopharma Corporation
AB-729, our RNAi therapeutic, provided robust and comparable HBsAg declines in both HBeAg+ and HBeAg- patients 50% (16 out of 32) of patients maintained HBsAg levels below 100 IU/mL 24 weeks after...
immunocore-logo-2018
Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™
June 25, 2022 04:00 ET | Immunocore Holdings Limited
PRESS RELEASE Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™ IMC-I109V, T cell receptor...
Nasdaq.jpg.prdesk.globenewswire.jpg
19th Consecutive Nasdaq Closing Cross Sets Record for Number of Shares Traded During 2022 Russell US Indexes Reconstitution
June 24, 2022 17:02 ET | Nasdaq, Inc.
NEW YORK, June 24, 2022 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) today announced the Nasdaq Closing Cross had a record day as it was used for the 19th consecutive year to rebalance...
Mercurity Fintech Holding Inc. Regains Compliance with Nasdaq Listing Rule 5250(c)(1)
June 24, 2022 17:00 ET | Mercurity Fintech Holding Inc.
SHENZHEN, China, June 24, 2022 (GLOBE NEWSWIRE) -- Mercurity Fintech Holding Inc. (the "Company" or "MFH") (Nasdaq: MFH), a digital fintech group powered by blockchain technology, today announced...
Yotta Acquisition Corporation Announces the Separate Trading of its Common Stock, Warrants and Rights, Commencing June 27, 2022
June 24, 2022 16:30 ET | Yotta Acquisition Corporation
NEW YORK, June 24, 2022 (GLOBE NEWSWIRE) -- Yotta Acquisition Corporation (“YOTA”) announced today that, commencing June 27, 2022, holders of the units sold in the Company’s initial public offering...
Century_PrimaryLogo_pfade_RGB_RZ.png
Century Therapeutics Announces Its Addition to the Russell Microcap® Index
June 24, 2022 16:30 ET | Century Therapeutics, Inc.
PHILADELPHIA, June 24, 2022 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in...
Borqs Technologies Announces Reverse Stock Split
June 24, 2022 16:30 ET | Borqs Technologies, Inc.
SANTA CLARA, Calif., June 24, 2022 (GLOBE NEWSWIRE) -- Borqs Technologies, Inc. (Nasdaq: BRQS, “Borqs”, or the “Company”), a global provider of 5G wireless solutions, Internet of Things (IoT)...